Beacon Pharmaceuticals Ltd. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was BDT 2,077.82 million compared to BDT 2,183.58 million a year ago. Net income was BDT 246.33 million compared to BDT 233.85 million a year ago. Basic earnings per share from continuing operations was BDT 1.07 compared to BDT 1.01 a year ago.
For the six months, sales was BDT 4,342.72 million compared to BDT 3,730.62 million a year ago. Net income was BDT 598.3 million compared to BDT 291 million a year ago. Basic earnings per share from continuing operations was BDT 2.59 compared to BDT 1.26 a year ago.